NEOPLAST
0821.712.437 · rovalta.com · 23/09/2026
NEOPLAST
Overview
What does NEOPLAST do?
NEOPLAST is a Private company with limited liability incorporated in 2009. Its main activity is: Specialist medical practice activities. Its registered office is in Meise.
1860 Meise · FlandreSee on map
Trend over 17 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||||||||
| Gross margin | 513,5 k € | +21.4% | 422,9 k € | -40.0% | 705,1 k € | -15.2% | 831,2 k € | -40.3% | 1,4 M € | +168% | 519,3 k € | +130% | 225,5 k € | -35.4% | 349 k € | -2.9% | 359,4 k € | -44.3% | 644,7 k € | +12.6% | 572,6 k € | +12.6% | 508,6 k € | +38.2% | 367,9 k € | +24.7% | 295 k € | -31.7% | 431,8 k € | +28.1% | 337,1 k € | -3.8% | 350,4 k € |
| EBITDA | 502,8 k € | +22.3% | 411,2 k € | -40.9% | 696,1 k € | -15.4% | 823 k € | -40.5% | 1,4 M € | +169% | 515,1 k € | +132% | 221,8 k € | -35.8% | 345,4 k € | -2.9% | 355,8 k € | -44.5% | 641,2 k € | +12.7% | 569,2 k € | +12.6% | 505,4 k € | +39.1% | 363,5 k € | +24.8% | 291,2 k € | -31.9% | 427,6 k € | +48.3% | 288,3 k € | -17.4% | 349,1 k € |
| Operating result | 488,4 k € | +23.0% | 397 k € | -41.8% | 682,3 k € | -15.7% | 809,2 k € | -40.9% | 1,4 M € | +173% | 501,3 k € | +141% | 208,1 k € | -37.3% | 331,6 k € | -3.1% | 342 k € | -45.5% | 627,3 k € | +13.0% | 555,2 k € | +13.0% | 491,5 k € | +40.9% | 348,9 k € | +30.6% | 267,1 k € | -33.9% | 403,8 k € | +57.8% | 256 k € | -23.7% | 335,3 k € |
| Net result | 422 k € | -65.4% | 1,2 M € | +145% | 497,8 k € | -21.1% | 630,6 k € | -31.5% | 920,6 k € | +125% | 409,5 k € | +74.4% | 234,7 k € | +112% | 111 k € | -54.4% | 243,3 k € | -41.2% | 414 k € | +540% | 64,7 k € | -82.5% | 369,1 k € | +33.4% | 276,6 k € | +8.5% | 254,9 k € | +7.5% | 237,1 k € | +42.0% | 167 k € | -26.2% | 226,1 k € |
| Balance sheet | |||||||||||||||||||||||||||||||||
| Equity | 4,5 M € | +2.5% | 4,4 M € | +32.1% | 3,3 M € | +9.0% | 3 M € | +10.0% | 2,8 M € | +26.1% | 2,2 M € | +22.9% | 1,8 M € | +15.1% | 1,6 M € | -6.3% | 1,7 M € | +17.2% | 1,4 M € | +41.3% | 1 M € | -3.4% | 1 M € | +35.1% | 767,3 k € | +49.1% | 514,6 k € | +98.1% | 259,7 k € | -38.5% | 422,6 k € | +52.1% | 277,9 k € |
| Total assets | 4,6 M € | +4.5% | 4,4 M € | +31.4% | 3,3 M € | +6.6% | 3,1 M € | +0.2% | 3,1 M € | +32.0% | 2,4 M € | +16.3% | 2 M € | +10.6% | 1,8 M € | -4.4% | 1,9 M € | +12.9% | 1,7 M € | +19.6% | 1,4 M € | -25.5% | 1,9 M € | +44.8% | 1,3 M € | +37.4% | 963,2 k € | -5.5% | 1 M € | +2.8% | 990,9 k € | +127% | 435,8 k € |
| Cash | 299,5 k € | +86.2% | 160,9 k € | -18.0% | 196,3 k € | +109% | 94 k € | -76.7% | 403,7 k € | +131% | 174,9 k € | +52.0% | 115,1 k € | -53.9% | 249,7 k € | -24.1% | 329,1 k € | +6.4% | 309,2 k € | +573% | 45,9 k € | +85.3% | 24,8 k € | -77.9% | 112,1 k € | +421% | 21,5 k € | +36.1% | 15,8 k € | -87.4% | 125,9 k € | -48.9% | 246,5 k € |
| Debts | 88,8 k € | +4394% | 2 k € | -89.2% | 18,3 k € | -77.6% | 81,7 k € | -76.9% | 353,1 k € | +107% | 170,8 k € | -31.3% | 248,8 k € | -13.5% | 287,5 k € | +7.6% | 267,1 k € | -8.1% | 290,5 k € | -31.6% | 425 k € | -51.7% | 879,4 k € | +59.0% | 553,1 k € | +24.6% | 443,8 k € | -41.3% | 756,4 k € | +33.1% | 568,2 k € | +266% | 155,1 k € |
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2025 · 1 active · 1 ended
Active mandates
Ended mandates
Other companies at this address
| Company | CBE no. |
|---|---|
ATLAS FINANCE INVEST● Active | 0478.738.253 |
ATLAS KLINIEK● Active | 0866.595.921 |
GREEN SEED BELGIUM● Active | 0473.307.936 |
Financials
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 27/03/2026 | 07/07/2025 | 13/05/2024 | 17/05/2023 | 30/06/2022 | 25/05/2021 |
| General meeting | 12/03/2026 | 27/06/2025 | 03/05/2024 | 21/04/2023 | 29/06/2022 | 21/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
18 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 12/03/2026 | 27/03/2026 | Dutch | |
| Abridged model | 31/12/2024 | 27/06/2025 | 07/07/2025 | Dutch | |
| Abridged model | 31/12/2023 | 03/05/2024 | 13/05/2024 | Dutch | |
| Abridged model | 31/12/2022 | 21/04/2023 | 17/05/2023 | Dutch | |
| Abridged modelCorrection | 31/12/2021 | 29/06/2022 | 30/06/2022 | Dutch | |
| Abridged model | 31/12/2021 | 26/03/2022 | 25/04/2022 | Dutch | |
| Abridged model | 31/12/2020 | 21/05/2021 | 25/05/2021 | Dutch | |
| Abridged model | 31/12/2019 | 26/06/2020 | 06/07/2020 | Dutch | |
| Abridged model | 31/12/2018 | 28/06/2019 | 26/07/2019 | Dutch | |
| Abridged model | 31/12/2017 | 29/06/2018 | 23/08/2018 | Dutch | |
| Abridged model | 31/12/2016 | 30/06/2017 | 24/08/2017 | Dutch | |
| Abridged model | 31/12/2015 | 24/06/2016 | 31/08/2016 | Dutch | |
| Abridged model | 31/12/2014 | 26/06/2015 | 31/08/2015 | Dutch | |
| Abridged model | 31/12/2013 | 27/06/2014 | 29/09/2014 | Dutch | |
| Abridged model | 31/12/2012 | 28/06/2013 | 30/08/2013 | Dutch | |
| Abridged model | 31/12/2011 | 29/06/2012 | 24/08/2012 | Dutch | |
| Abridged model | 31/12/2010 | 24/06/2011 | 31/08/2011 | Dutch | |
| Abridged model | 31/12/2009 | 25/06/2010 | 30/08/2010 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 5 M€ and 10 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2025 · 1 active · 1 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025422 k €↓
- 2024Annual accounts 20241,2 M €↑
- 2023Annual accounts 2023497,8 k €↓
- 2022Annual accounts 2022630,6 k €↓
- 2021Annual accounts 2021920,6 k €↑
- 2020Annual accounts 2020409,5 k €↑
- 2019Annual accounts 2019234,7 k €↑
- 2018Annual accounts 2018111 k €↓
- 2017Annual accounts 2017243,3 k €↓
- 2016Annual accounts 2016414 k €↑
- 2015Annual accounts 201564,7 k €↓
- 2014Annual accounts 2014369,1 k €↑
- 2013Annual accounts 2013276,6 k €↑
- 2012Annual accounts 2012254,9 k €↑
- 2011Annual accounts 2011237,1 k €↑
- 2010Annual accounts 2010167 k €↓
- 2009Annual accounts 2009226,1 k €
- 23/12/2009IncorporationPrivate company with limited liability